The current S&P 500 P/E ratio is 24.99 (as of 9/27/16, end of day) – to compare with a mean P/E of 15.62 and median of 14.64 (sample data since 1870). Stocks are expensive – but we are NOT in a bubble, not yet anyhow. Current S&P 500 PE Ratio: 24.99 +0.16 (0.64%) (4:08 pm EDT, Tue Sep 27)
Price to earnings ratio, based on trailing twelve month “as reported” earnings. Current PE is estimated from latest reported earnings and current market price. No matter what – US rate hikes, global growth concerns, the volatility of oil and other commodities, bondrama, Russia and China’s military ambitions, La Hilary vs. The Donald, etc. – great companies will continue to thrive. If you are a long-term investor, buy opportunities are out there. Examples? Some energy issues (despite the sector’s recent advance) are still reasonably priced. No wonder Warren Buffett not long ago added to his Phillips 66 (PSX) holdings. Some biotech and healthcare issues seem to present investors with real long-term appreciation potential at current prices. Think Biogen (BIIB) (An insider bought a massive amount of BIIB on 10/22 and 10/23/2015), HCA Holdings (HCA), Jazz Pharmaceuticals plc (JAZZ), Alnylam Pharmaceuticals (ALNY), Alexion Pharmaceuticals, Inc. (ALXN), Incyte Corporation (INCY), Regeneron Pharmaceuticals Inc (REGN) and a few others. Financials are also increasingly appealing; no wonder CEO James Dimon not long ago bought $28 million worth of JPMorgan & Co (JPM) shares (2/11/16). Ditto for some retailers and casino stocks. J C Penney Company Inc (JCP), Macy’s, Inc. (M), Coach (COH), Michael Kors (KORS), Dollar General (DG) may still be worth investigating. Casino equities led by Wynn Resorts (WYNN) (up over the past few months after a bout of insider purchases and now likely consolidating) may continue to outperform (after underperforming for months). Please, see below and our daily updates for insiders and hedge funds’ takes and many more ideas…
Recently or earlier this year insiders have bought shares of (new today) Hyster-Yale Materials Handling Inc (HY), Par Pacific Holdings, Inc. (PARR), Vishay Precision Group Inc (VPG), Enphase Energy Inc (ENPH), CareDx Inc (CDNA), L.B. Foster Co (FSTR), Immune Design Corp (IMDZ), Noble Midstream Partners LP (NBLX), Capricor Therapeutics Inc (CAPR), HD Supply Holdings Inc (HDS), Endurance International Group Hldgs Inc (EIGI), Aquinox Pharmaceuticals Inc (AQXP), First Guaranty Bancshares, Inc. (FGBI), Chesapeake Energy Corporation (CHK), Atlas Energy Group LLC (ATLS), Community Healthcare Trust Inc (CHCT), Argos Therapeutics Inc (ARGS), IMPAC Mortgage Holdings, Inc (IMH), Immune Design Corp (IMDZ), Ulta Salon, Cosmetics & Fragrance, Inc. (ULTA), At Home Group (HOME), Cheniere Energy, Inc. (LNG), Platform Specialty Products Corp (PAH), FB Financial Corp (FBK), Phillips 66 (PSX), Akamai Technologies, Inc. (AKAM), Performance Sports Group Ltd (PSG), NGL Energy Partners LP (NGL), Inovalon Holdings Inc (INOV), Adamas Pharmaceuticals Inc (ADMS), Array Biopharma Inc (ARRY), Pinnacle Entertainment Inc (PNK), L.B. Foster Co (FSTR), GameStop Corp (GME), Proteostasis Therapeutics Inc (PTI), Viewray Inc (VRAY), Dominion Midstream Partners LP (DM), Freshpet Inc (FRPT), Itron, Inc.(ITRI), Pantheon NV (PTHN), WisdomTree Investments, Inc. (WETF), Workhorse Group Inc (WKHS), Bravo Brio Restaurant Group, Inc. (BBRG), Seattle Genetics, Inc. (SGEN), Madison Square Garden Co (MSGN), MSG Networks Inc (MSG), La Jolla Pharmaceutical Company (LJPC), United Auto Group (PAG), American Assets Trust, Inc (AAT), PBF Energy Inc (PBF), Restaurant Brands International Inc (QSR), KAR Auction Services Inc (KAR), Aegerion Pharmaceuticals, Inc. (AEGR), Western Refining Logistics LP (WNRL), Inovalon Holdings Inc (INOV), Kinsale Capital Group Inc (KNSL), Associated Banc Corp (ASB), OCI Partners LP (OCIP), Dell Technologies (DVMT), Wesco Aircraft Holdings Inc (WAIR), Dominion Midstream Partners LP (DM), Advance Auto Parts (AAP), Herbalife (HLF), ConocoPhillips (COP), Dollar General (DG), Norwegian Cruise Line Holdings Ltd (NCLH), Gogo (GOGO), MINDBODY Inc (MB).
(The aforementioned list only includes a subset of companies where insider purchases have taken place; it is pre-screened by our in-house team of .o3 analysts along criteria that have yet to be determined!)
1. We are ourselves and nobody else but ourselves, which is us, so we are not responsible for the people who are not us and we are serious it’s not a joke. 2. We are not brokers we wanted to be brokers but there are exams and we can’t take too many exams because they are difficult and so we are not brokers nor do we intend to become brokers as long as there are exams. 3. We in no way claim that we have investigated or even considered or even tried to consider contemplating not to mention ignited a thought process revolving around the[...]